Alzheimer Disease Tied to Adverse Financial Events
FRIDAY, Dec. 4, 2020 -- Alzheimer disease and related dementias (ADRDs) are associated with adverse financial events years prior to clinical diagnosis, according to a study published online Nov. 30 in JAMA Internal Medicine.
Lauren Hersch Nicholas, Ph.D., from Johns Hopkins University in Baltimore, and colleagues linked consumer credit report outcomes (1999 to 2018) to Medicare claims data for 81,364 Medicare beneficiaries living in single-person households to assess the frequency and extent of adverse financial events before and after an ADRD diagnosis.
The researchers found that single Medicare beneficiaries diagnosed with ADRD were more likely to miss payments on credit accounts as early as six years prior to diagnosis versus demographically similar beneficiaries without ADRD (absolute difference, 0.4 percentage points [pp]) and were more likely to develop subprime credit scores 2.5 years prior to diagnosis (absolute difference, 0.38 pp). Patients with ADRD remained more likely to miss payments than similar beneficiaries who did not develop ADRD by the quarter after diagnosis (absolute difference, 1.0 pp) and to have subprime credit scores than those without ADRD (absolute difference, 0.70 pp). Among patients with ADRD in lower-education census tracts, adverse financial events were more common. These patterns of adverse financial events associated with ADRD were unique compared with other medical conditions (e.g., glaucoma, hip fracture).
"Even without effective medical treatments, earlier detection of cognitive impairment might help protect older adults and their families from adverse financial outcomes," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: December 2020
Read this next
FRIDAY, Jan. 15, 2021 -- Individuals with primary progressive aphasia (PPA) associated with Alzheimer disease (AD) have longitudinally preserved episodic memory, according to a...
THURSDAY, Jan. 14, 2021 -- Greater levels of moderate- to vigorous-intensity physical activity (MVPA) in midlife may protect against cerebrovascular sequelae in later life,...
WEDNESDAY, Jan. 13, 2021 -- Measures of cognitive performance show decline from premenopause to later menopause stages among low-income women of color, according to a study...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.